Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FFP vs FP24 in Neonates
NCT02774317Phase 4Withdrawn
- Sponsor
- University of Chicago
- Start
- Oct 2017
- Primary completion
- Jun 2020
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of plasma frozen within 24 hours in blood coagulation disorder (2 arms), sponsored by University of Chicago. Primary endpoint: Number of neonates with corrected International Normalization Ratio (INR) at 24 hours. Planned start Oct 2017; status: withdrawn.
02
Drugs
plasma frozen within 24 hours
03
Conditions
blood coagulation disorder
Beyond the preview
Go deeper on NCT02774317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02774317.